Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BALOXAVIR MARBOXIL vs BAMLANIVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BALOXAVIR MARBOXIL vs BAMLANIVIMAB: Safety Overview

Metric BALOXAVIR MARBOXIL BAMLANIVIMAB
Total FAERS Reports 2,010 5,280
Deaths Reported 120 307
Death Rate 6.0% 5.8%
Hospitalizations 378 2,175
Average Patient Age 37.8 yrs 63.6 yrs
% Female Patients 53.8% 50.5%
FDA Approval Date Mar 18, 2021 N/A
Manufacturer Genentech, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A